XL-protein and Phylogica partner to use XL-protein's PASylation technology to extend the half-life of Phylogica's Phylomer peptides

XL-protein GmbH

Germany / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Phylogica Ltd.

Australia / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced